A real-life assessment of the management of chronic urticaria in primary care by general practitioners in the North of France. - Université de Lille Accéder directement au contenu
Article Dans Une Revue Annales de Dermatologie et de Vénéréologie Année : 2021

A real-life assessment of the management of chronic urticaria in primary care by general practitioners in the North of France.

Résumé

Material and methods Chronic urticaria (CU) is a common skin disease affecting around 0.5 to 1% of the general population [1]. The guidelines for therapeutic management, updated in 2018, recommend omalizumab (Xolair®), the first anti-IgE biotherapy, as third-line therapy, after second-generation (2G) anti-histamines (anti-H1), whether or not at increased dosage, but with restricted access to specialist physicians in France [2]. There are few studies on CU management in primary care. This disease may cause difficulties for general practitioners (GPs) in diagnosis and therapy, especially since the prescription of corticosteroids increases the risk of chronicity and relapses [3]. We aimed to assess the management of CU by GPs in the North of France using an anonymous survey in order to better understand and improve the healthcare pathway in primary care.
Fichier non déposé

Dates et versions

hal-04446143 , version 1 (08-02-2024)

Identifiants

Citer

Frédéric Dezoteux, B. Adam, E. Pape, S. Azib-Meftah, Matthieu Calafiore, et al.. A real-life assessment of the management of chronic urticaria in primary care by general practitioners in the North of France.. Annales de Dermatologie et de Vénéréologie, 2021, Annales de Dermatologie et de Vénéréologie, 48 (4), pp.P 266-268. ⟨10.1016/j.annder.2021.04.009⟩. ⟨hal-04446143⟩

Collections

RIIP UNIV-LILLE
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More